PHARM.ST
Price:
$0.56
Market Cap:
$12.93M
Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company is based in Lund, Sweden.
Industry
Biotechnology
IPO Date
2021-03-31
Stock Exchange
STO
Ticker
PHARM.ST
According to Pharmiva AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 5.46. This represents a change of 51.43% compared to the average of 3.60 of the last 4 quarters.
The mean historical Current Ratio of Pharmiva AB (publ) over the last ten years is 4.98. The current 5.46 Current Ratio has changed 10.87% with respect to the historical average. Over the past ten years (40 quarters), PHARM.ST's Current Ratio was at its highest in in the June 2021 quarter at 11.08. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
4.98
Median
4.96
Minimum
2.57
Maximum
7.41
Discovering the peaks and valleys of Pharmiva AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 74.29%
Maximum Annual Current Ratio = 7.41
Minimum Annual Increase = -26.32%
Minimum Annual Current Ratio = 2.57
| Year | Current Ratio | Change |
|---|---|---|
| 2022 | 5.46 | -26.32% |
| 2021 | 7.41 | 65.57% |
| 2020 | 4.47 | 74.29% |
The current Current Ratio of Pharmiva AB (publ) (PHARM.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
5.78
5-year avg
4.98
10-year avg
4.98
Pharmiva AB (publ)’s Current Ratio is greater than Idogen AB (publ) (1.67), greater than Amniotics AB (publ) (1.17), greater than Ziccum AB (publ) (0.36), greater than Diagonal Bio AB (publ) (1.94), greater than Learning 2 Sleep L2S AB (publ) (0.14), less than VibroSense Dynamics AB (5.91), greater than Pharmacolog i Uppsala AB (publ) (2.28), greater than AegirBio AB (publ) (0.36), greater than Cyxone AB (publ) (4.01), less than Pexa AB (6.44),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.67 | $12.79M | |
| 1.17 | $14.76M | |
| 0.36 | $8.56M | |
| 1.94 | $20.20M | |
| 0.14 | $11.68M | |
| 5.91 | $12.70M | |
| 2.28 | $10.70M | |
| 0.36 | $15.43M | |
| 4.01 | $6.75M | |
| 6.44 | $10.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmiva AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharmiva AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Pharmiva AB (publ)'s Current Ratio?
How is the Current Ratio calculated for Pharmiva AB (publ) (PHARM.ST)?
What is the highest Current Ratio for Pharmiva AB (publ) (PHARM.ST)?
What is the 3-year average Current Ratio for Pharmiva AB (publ) (PHARM.ST)?
What is the 5-year average Current Ratio for Pharmiva AB (publ) (PHARM.ST)?
How does the current Current Ratio for Pharmiva AB (publ) (PHARM.ST) compare to its historical average?